Literature DB >> 1175679

Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.

O G Nilsen, D Fremstad, S Jacobsen.   

Abstract

The purpose of this work was to identify the main quinidine binding molecules of rat serum and those macromolecules responsible for increased quinidine binding in serum from rats with acute anuria. Rat sera were fractionated by gel filtration, ultracentrifugation and anion exchange chromatography. The binding of quinidine to sera and serum fractions was determined by equilibrium dialysis. The experiments demonstrated that albumin and lipoproteins are the main quinidine binding molecules in serum from normal and anuric rats. The increased binding by serum from anuric rats is due to both serum lipoproteins and albumin, even though the concentration of albumin is decreased from 2.8 to 1.7 g/100 ml. The increased binding to albumin may be due to conformation changes induced by endogenous substances. The increased binding to lipoproteins may be caused by an increased concentration of pre-beta-lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1175679     DOI: 10.1016/0014-2999(75)90147-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Increased plasma binding of quinidine after surgery: a preliminary report.

Authors:  D Fremstad; K Bergerud; J F Haffner; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

2.  Influence of acute renal failure on the protein binding of drugs in animals and in man.

Authors:  F M Belpaire; M G Bogaert; M M Mussche
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  Decreased binding of drugs and dyes to plasma proteins from rats with acute renal failure: effects of ureter ligation and intramuscular injection of glycerol.

Authors:  C J Bowmer; W E Lindup
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

4.  Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.

Authors:  M Pérez-Mateo; S Erill
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.